Foster Dykema Cabot & Partners, LLC Abbott Laboratories Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 6,151 shares of ABT stock, worth $681,346. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,151
Previous 6,266
1.84%
Holding current value
$681,346
Previous $712 Million
10.26%
% of portfolio
0.06%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,125Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.5 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.24 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$7.95 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.34 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $194B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...